Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myeloproliferative Disorders | 7 | 2023 | 606 | 3.470 |
Why?
|
Polycythemia Vera | 5 | 2023 | 164 | 3.080 |
Why?
|
Thrombocythemia, Essential | 4 | 2022 | 105 | 2.900 |
Why?
|
Primary Myelofibrosis | 2 | 2023 | 215 | 1.400 |
Why?
|
Janus Kinase 2 | 3 | 2023 | 528 | 0.910 |
Why?
|
Pregnancy Complications, Hematologic | 2 | 2021 | 183 | 0.820 |
Why?
|
Blast Crisis | 1 | 2021 | 103 | 0.790 |
Why?
|
Calreticulin | 1 | 2019 | 98 | 0.670 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 1671 | 0.660 |
Why?
|
Plasmacytoma | 1 | 2019 | 183 | 0.640 |
Why?
|
Splanchnic Circulation | 1 | 2017 | 110 | 0.600 |
Why?
|
Live Birth | 1 | 2020 | 512 | 0.570 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 689 | 0.570 |
Why?
|
Meningeal Carcinomatosis | 1 | 2017 | 65 | 0.560 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2016 | 53 | 0.550 |
Why?
|
Skull Base Neoplasms | 1 | 2019 | 284 | 0.520 |
Why?
|
Abortion, Spontaneous | 1 | 2020 | 544 | 0.520 |
Why?
|
Food Microbiology | 1 | 2015 | 78 | 0.500 |
Why?
|
Acid Phosphatase | 1 | 2014 | 143 | 0.470 |
Why?
|
Listeriosis | 1 | 2015 | 149 | 0.470 |
Why?
|
Remission Induction | 1 | 2018 | 2386 | 0.440 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2016 | 640 | 0.440 |
Why?
|
Peritonitis | 1 | 2015 | 365 | 0.430 |
Why?
|
Hematologic Neoplasms | 2 | 2021 | 1832 | 0.430 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2018 | 3523 | 0.410 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2021 | 5442 | 0.410 |
Why?
|
Janus Kinases | 2 | 2023 | 244 | 0.370 |
Why?
|
Methotrexate | 1 | 2016 | 1727 | 0.360 |
Why?
|
Fruit | 1 | 2015 | 1142 | 0.340 |
Why?
|
Isoenzymes | 1 | 2014 | 1726 | 0.330 |
Why?
|
Venous Thrombosis | 1 | 2017 | 1239 | 0.310 |
Why?
|
Tissue Donors | 1 | 2017 | 2240 | 0.300 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3703 | 0.290 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2016 | 1378 | 0.280 |
Why?
|
Anticoagulants | 1 | 2021 | 4599 | 0.280 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11524 | 0.270 |
Why?
|
Protein Kinase Inhibitors | 2 | 2021 | 5535 | 0.250 |
Why?
|
Neoplasms | 3 | 2022 | 21683 | 0.240 |
Why?
|
Models, Biological | 1 | 2020 | 9583 | 0.240 |
Why?
|
Mutation | 4 | 2023 | 29786 | 0.230 |
Why?
|
T-Lymphocytes | 2 | 2022 | 10180 | 0.230 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2541 | 0.200 |
Why?
|
Multiple Myeloma | 1 | 2019 | 5181 | 0.190 |
Why?
|
Cyclophosphamide | 2 | 2017 | 2242 | 0.190 |
Why?
|
Biology | 1 | 2023 | 294 | 0.190 |
Why?
|
Disease Management | 2 | 2021 | 2459 | 0.190 |
Why?
|
Phlebotomy | 1 | 2021 | 141 | 0.190 |
Why?
|
STAT Transcription Factors | 1 | 2019 | 182 | 0.170 |
Why?
|
Macrophages | 1 | 2014 | 5655 | 0.170 |
Why?
|
Interferons | 1 | 2022 | 706 | 0.160 |
Why?
|
Receptors, Thrombopoietin | 1 | 2019 | 157 | 0.160 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5221 | 0.160 |
Why?
|
Platelet Count | 1 | 2020 | 781 | 0.150 |
Why?
|
Humans | 22 | 2023 | 744343 | 0.150 |
Why?
|
Drug Dosage Calculations | 1 | 2017 | 114 | 0.140 |
Why?
|
Signal Transduction | 1 | 2019 | 23403 | 0.140 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6364 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20129 | 0.130 |
Why?
|
Aged | 10 | 2021 | 163280 | 0.130 |
Why?
|
Disease Progression | 2 | 2023 | 13284 | 0.130 |
Why?
|
Histocompatibility | 1 | 2017 | 330 | 0.130 |
Why?
|
Brain Neoplasms | 1 | 2017 | 8863 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 35421 | 0.130 |
Why?
|
Vincristine | 1 | 2016 | 1039 | 0.120 |
Why?
|
Female | 13 | 2021 | 380194 | 0.120 |
Why?
|
Secondary Prevention | 1 | 2021 | 1530 | 0.120 |
Why?
|
Administration, Oral | 1 | 2021 | 3913 | 0.120 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 973 | 0.120 |
Why?
|
Middle Aged | 9 | 2021 | 213383 | 0.110 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2016 | 693 | 0.110 |
Why?
|
Listeria monocytogenes | 1 | 2015 | 250 | 0.110 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 294 | 0.110 |
Why?
|
Lung Neoplasms | 1 | 2017 | 13102 | 0.110 |
Why?
|
Tissue Array Analysis | 1 | 2014 | 553 | 0.100 |
Why?
|
Prednisone | 1 | 2016 | 1574 | 0.100 |
Why?
|
Adult | 8 | 2021 | 214055 | 0.100 |
Why?
|
Drug Resistance | 1 | 2017 | 1609 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3586 | 0.090 |
Why?
|
Male | 11 | 2021 | 350118 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3176 | 0.090 |
Why?
|
Gene Frequency | 1 | 2017 | 3588 | 0.090 |
Why?
|
Prognosis | 3 | 2020 | 29063 | 0.090 |
Why?
|
Pituitary-Adrenal System | 1 | 2013 | 553 | 0.090 |
Why?
|
Doxorubicin | 1 | 2016 | 2234 | 0.090 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4776 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3278 | 0.090 |
Why?
|
Aspirin | 1 | 2021 | 3282 | 0.090 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2013 | 703 | 0.080 |
Why?
|
Pregnancy | 2 | 2021 | 29144 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 3068 | 0.080 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9734 | 0.070 |
Why?
|
Growth Inhibitors | 1 | 2008 | 385 | 0.070 |
Why?
|
Retrospective Studies | 3 | 2021 | 77449 | 0.070 |
Why?
|
Young Adult | 3 | 2018 | 56430 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2013 | 1403 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 9959 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2017 | 63114 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57776 | 0.060 |
Why?
|
Melanocytes | 1 | 2008 | 515 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2015 | 1863 | 0.060 |
Why?
|
Social Class | 1 | 2013 | 1999 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2866 | 0.060 |
Why?
|
Graft vs Host Disease | 1 | 2017 | 2957 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10252 | 0.060 |
Why?
|
Age Factors | 2 | 2019 | 18370 | 0.060 |
Why?
|
Antigens, CD | 1 | 2014 | 4026 | 0.060 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2008 | 838 | 0.050 |
Why?
|
Genomics | 1 | 2019 | 5720 | 0.050 |
Why?
|
Mothers | 1 | 2013 | 2165 | 0.050 |
Why?
|
Risk Factors | 2 | 2020 | 72290 | 0.050 |
Why?
|
Hippocampus | 1 | 2013 | 3675 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2008 | 2007 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2017 | 21746 | 0.040 |
Why?
|
Animals | 2 | 2021 | 168757 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2008 | 5021 | 0.030 |
Why?
|
Mice | 1 | 2019 | 81183 | 0.030 |
Why?
|
Intelligence Tests | 1 | 2013 | 505 | 0.030 |
Why?
|
Association Learning | 1 | 2013 | 224 | 0.030 |
Why?
|
Brain | 1 | 2016 | 26385 | 0.020 |
Why?
|
Melanoma | 1 | 2008 | 5510 | 0.020 |
Why?
|
Saliva | 1 | 2013 | 809 | 0.020 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2008 | 112 | 0.020 |
Why?
|
Autocrine Communication | 1 | 2008 | 171 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2013 | 1826 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2008 | 913 | 0.020 |
Why?
|
Adenoviridae | 1 | 2008 | 1099 | 0.010 |
Why?
|
Regression Analysis | 1 | 2013 | 6459 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2008 | 1678 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3616 | 0.010 |
Why?
|
Up-Regulation | 1 | 2008 | 4217 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40561 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39050 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53288 | 0.010 |
Why?
|
Cell Movement | 1 | 2008 | 5217 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2008 | 10481 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 16689 | 0.010 |
Why?
|
Child | 1 | 2013 | 77709 | 0.000 |
Why?
|
Concepts
(137)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_